5 Keys to Patient Education on GLP-1 RAs for Weight Loss
As ‘magic’ weight loss drugs capture public attention, you’ve likely seen an uptick in patients asking about GLP-1 RAs for weight loss. As your go-to partner for cardiometabolic risk reduction research, industry news, and practical strategies, we’ve created this highly practical guide to help you educate patients on safe access to GLP-1 RAs for weight […]
Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care
The not-so-sudden rise of weight loss ”wonder” drugs for T2D and obesity This World Obesity Day, March 4, 2024, weight loss drugs dominate discussions and raise new questions for clinicians. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have been used to treat type 2 diabetes (T2D) since the approval of Byetta (exenatide) in 2005. In the […]
Lowering Blood Pressure Without Medication
Recently updated guidelines from the American Heart Association and the American College of Cardiology have contributed to a growing number of patients being diagnosed with hypertension. Lowering the threshold for hypertension from 140/90 to 130/80 mm Hg resulted in a significant increase of patients — with previously normal or slightly elevated blood pressure (BP) — […]
Weight Loss Counseling? Not So Much.
Adults who are overweight or obese report receiving little weight loss counseling, especially involving medications and surgery; however, many report trying to lose weight within the last 12 months, according to a speaker at ObesityWeek. “We know that less than 50% of patients with obesity have reported receiving weight loss counseling within a provider visit and most […]
